Status:
ACTIVE_NOT_RECRUITING
Effect of a Pharmacist-led, Collaborative Practice on Clinical Outcomes in Persons with Diabetes
Lead Sponsor:
Methodist Health System
Conditions:
Diabetes
Type2diabetes
Eligibility:
All Genders
18-100 years
Brief Summary
Diabetes is a complex chronic illness known for its high prevalence (11.3% in the United States), significant healthcare burdens in terms of cost and management, and high mortality rate (seventh leadi...
Detailed Description
Diabetes is a complex chronic illness known for its high prevalence (11.3% in the United States), significant healthcare burdens in terms of cost and management, and high mortality rate (seventh leadi...
Eligibility Criteria
Inclusion
- Adults \> 18 years old
- Minimum of two visits with clinical pharmacist during 2022
- Minimum of one HbA1c reading within 90 days prior to first visit AND one HgbA1c reading within 90 days after the last clinic encounter
Exclusion
- Clinic patients without diagnosis of type 1 diabetes mellitus or T2DM which, per ADA 2022 Standards of Care, is defined as an HbA1c of \>6.5%
Key Trial Info
Start Date :
April 6 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 3 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05995262
Start Date
April 6 2023
End Date
April 3 2025
Last Update
November 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Methodist Dallas Medical Center
Dallas, Texas, United States, 75237